Regeneron Pharmaceuticals Inc is ramping up efforts to develop a set of coronavirus treatments, which could be available for testing or use in some patients within a few months, the drugmaker said on Thursday.
The drugmaker on Tuesday expanded its arrangement with the U.S. Department of Health and Human Services to collaborate on developing a treatment, joining the race to develop a treatment for the virus that has killed more than 550 people.
Regeneron said the treatments could be made available through a "compassionate use" program that provides patients access to experimental drugs outside of a clinical trial when there are no viable alternatives.
"We're already scaling up one set of potential antibody treatments," Chief Scientific Officer George Yancopoulos said on a conference call with analysts.